MIM
Martin Investment Management Portfolio holdings
AUM
$390M
This Quarter Return
+6.24%
1 Year Return
+9.2%
3 Year Return
+57.18%
5 Year Return
+97.51%
10 Year Return
+265.79%
AUM
$348M
AUM Growth
+$348M
(+9.1%)
Cap. Flow
+$11.2M
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
55.24%
Holding
51
New
4
Increased
18
Reduced
17
Closed
1
Top Buys
| 1 |
Roper Technologies
ROP
|
$6.43M |
| 2 |
Helmerich & Payne
HP
|
$4.51M |
| 3 |
VeriSign
VRSN
|
$2.9M |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
$1.27M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$1.17M |
Top Sells
| 1 |
Novartis
NVS
|
$1.52M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
$1.41M |
| 3 |
BP
BP
|
$841K |
| 4 |
Mastercard
MA
|
$742K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$725K |
Sector Composition
| 1 | Technology | 30.05% |
| 2 | Healthcare | 25.19% |
| 3 | Financials | 15.57% |
| 4 | Industrials | 9.57% |
| 5 | Consumer Discretionary | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Novartis
NVS
$245B
| $27.3M | 7.85% | 296,449 -16,531 | -5% | -$1.52M |
|
2
Check Point Software Technologies
CHKP
$20.7B
| $26.8M | 7.71% | 206,211 +1,855 | +0.9% | +$241K |
|
3
Alcon
ALC
$39.5B
| $23.6M | 6.78% | 334,264 +2,935 | +0.9% | +$207K |
|
4
Sony
SONY
$165B
| $23.1M | 6.65% | 255,063 +2,955 | +1% | +$268K |
|
5
Apple
AAPL
$3.45T
| $21.9M | 6.31% | 132,906 +2,985 | +2% | +$492K |
|
6
Toyota
TM
$254B
| $19.6M | 5.64% | 138,440 +1,305 | +1% | +$185K |
|
|
7
Mastercard
MA
$538B
| $17.3M | 4.98% | 47,632 -2,041 | -4% | -$742K |
|
8
Thermo Fisher Scientific
TMO
$186B
| $12M | 3.44% | 20,745 -1,190 | -5% | -$686K |
|
|
9
Alphabet (Google) Class A
GOOGL
$2.57T
| $10.3M | 2.97% | 99,504 +11,273 | +13% | +$1.17M |
|
|
10
Berkshire Hathaway Class B
BRK.B
$1.09T
| $10.1M | 2.89% | 32,568 -2,348 | -7% | -$725K |
|
11
MSCI
MSCI
$43.9B
| $9.51M | 2.74% | 16,991 -357 | -2% | -$200K |
|
12
Booking.com
BKNG
$181B
| $9.21M | 2.65% | 3,474 -50 | -1% | -$133K |
|
13
Accenture
ACN
$162B
| $9.09M | 2.62% | 31,806 +572 | +2% | +$163K |
|
14
American Express
AXP
$231B
| $8.89M | 2.56% | 53,910 -2,234 | -4% | -$368K |
|
15
Bristol-Myers Squibb
BMY
$96B
| $8.86M | 2.55% | 127,762 +9,607 | +8% | +$666K |
|
16
Verisk Analytics
VRSK
$37.5B
| $7.83M | 2.25% | 40,800 -1,406 | -3% | -$270K |
|
17
Procter & Gamble
PG
$368B
| $7.5M | 2.16% | 50,425 -2,294 | -4% | -$341K |
|
18
Stryker
SYK
$150B
| $7.2M | 2.07% | 25,210 -1,122 | -4% | -$320K |
|
19
L3Harris
LHX
$51.9B
| $7.17M | 2.06% | 36,536 -927 | -2% | -$182K |
|
20
Johnson & Johnson
JNJ
$427B
| $7.11M | 2.05% | 45,870 +173 | +0.4% | +$26.8K |
|
21
General Dynamics
GD
$87.3B
| $6.83M | 1.96% | 29,920 -1,027 | -3% | -$234K |
|
22
S&P Global
SPGI
$167B
| $6.6M | 1.9% | 19,142 -580 | -3% | -$200K |
|
23
FMC
FMC
$4.88B
| $6.52M | 1.88% | 53,380 -369 | -0.7% | -$45.1K |
|
|
24
Roper Technologies
ROP
$56.6B
| $6.43M | 1.85% | +14,581 | New | +$6.43M |
|
|
25
VeriSign
VRSN
$25.5B
| $6.37M | 1.83% | 30,163 +13,723 | +83% | +$2.9M |
|